Gjorgjieva, M.; Ay, A.-S.; Correia de Sousa, M.; Delangre, E.; Dolicka, D.; Sobolewski, C.; Maeder, C.; Fournier, M.; Sempoux, C.; Foti, M.
MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver. Cells 2022, 11, 2860.
https://doi.org/10.3390/cells11182860
AMA Style
Gjorgjieva M, Ay A-S, Correia de Sousa M, Delangre E, Dolicka D, Sobolewski C, Maeder C, Fournier M, Sempoux C, Foti M.
MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver. Cells. 2022; 11(18):2860.
https://doi.org/10.3390/cells11182860
Chicago/Turabian Style
Gjorgjieva, Monika, Anne-Sophie Ay, Marta Correia de Sousa, Etienne Delangre, Dobrochna Dolicka, Cyril Sobolewski, Christine Maeder, Margot Fournier, Christine Sempoux, and Michelangelo Foti.
2022. "MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver" Cells 11, no. 18: 2860.
https://doi.org/10.3390/cells11182860
APA Style
Gjorgjieva, M., Ay, A. -S., Correia de Sousa, M., Delangre, E., Dolicka, D., Sobolewski, C., Maeder, C., Fournier, M., Sempoux, C., & Foti, M.
(2022). MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver. Cells, 11(18), 2860.
https://doi.org/10.3390/cells11182860